NXPO, in collaboration with 21 organizations joining forces in the Thailand Synthetic Biology (SynBio) Consortium, recently hosted the SynBio Consortium Annual Meeting. The annual gathering held under the concept of Advancing the Game Changer on 10 November 2023 offered a platform for knowledge exchange in synthetic biology technology across various industrial sectors and investors, featuring activities such as seminars and a technology showcase.
Synthetic biology is gaining increased attention from both the public and private sectors in Thailand. While large corporates and startups are boosting their investment in synthetic biology technology, the government is directing more funding towards research, infrastructure and manpower development. Regulatory framework and investment promotion measures are also being established to further support the private sector’s engagement in this emerging field.
Ms. Sirinya Lim, Senior Director of Innovation Economic Policy Department at NXPO, participated in a panel discussion, providing information on measures and incentives from the government to support SynBio activities. She discussed synthetic biology landscape and opportunities in Thailand, particularly in precision fermentation technology, which brings added value to various industries. In agriculture, precision fermentation can contribute to the production of biofertilizers, potentially reducing the fertilizer import which reaches a value of THB 100 billion annually. Biofertilizers also play a crucial role in supporting regenerative agriculture – farming practices that promote soil health, climate protection, and biodiversity.
SynBio’s impact also extends to the food industry, facilitating the production of functional ingredients and alternative proteins. In the medical field, SynBio is instrumental in the creation of cell therapy products, particularly CAR-T cell therapy which has been experiencing significant market growth. The transition to biomaterials, biofuels, hydrogen energy, and sustainable aviation fuel (SAF) are all enabled by SynBio. Ms. Sirinya emphasized Thailand’s potential to develop this emerging technology, citing the expertise of local researchers and capable companies.
In term of the government’s support, NXPO plays a key role in facilitating activities of SynBio Consortium and providing recommendations to the government on investment levels and priorities. Accurate information provided by consortium members serves as invaluable insights for NXPO in designing appropriate measures to drive SynBio development in Thailand.
SynBio Consortium was founded in 2021, marking a collaborative effort among universities, research institutions, and both public and private sectors to strengthen Thailand’s SynBio research and investment, enhancing Thailand’s competitiveness on the global stage.
